By doing this, they hope to boost the presence of generic drugs and biosimilars within the sector.

他们希望通过这样做来提升该行业非专利药和生物仿制药的存在比例。

Bringing a biosimilar to market can cost as much as 250 million dollars.

将一种生物仿制药推向市场可能要花费高达 2.5 亿美元。